Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-013614
Filing Date
2014-03-21
Accepted
2014-03-21 12:04:32
Documents
1
Period of Report
2014-03-19

Document Format Files

Seq Description Document Type Size
1 rrd406064.html 4  
1 rrd406064.xml 4 5144
  Complete submission text file 0001181431-14-013614.txt   6683
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Issuer) CIK: 0001369786 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SAGENT PHARMACEUTICALS, INC. 1901 N. ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address
Patterson Albert (Reporting) CIK: 0001517895 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35144 | Film No.: 14709250